Literature DB >> 30569182

Comparison between M-score and LR-M in the reporting system of contrast-enhanced ultrasound LI-RADS.

Li-Da Chen1, Si-Min Ruan1, Yuan Lin2, Jin-Yu Liang1, Shun-Li Shen3, Hang-Tong Hu1, Yang Huang1, Wei Li1, Zhu Wang1, Xiao-Yan Xie1, Ming-De Lu1,3, Ming Kuang1,3, Wei Wang4.   

Abstract

OBJECTIVE: To develop a contrast-enhanced ultrasound (CEUS) M-score and compare it with LR-M in CEUS Liver Imaging Reporting and Data System (LI-RADS).
METHODS: We retrospectively enrolled 105 consecutive high-risk patients with hepatocellular carcinoma (HCC) and 105 with intrahepatic cholangiocarcinoma (ICC). The subjects were selected by propensity score matching between November 2003 and December 2017. A CEUS M-score for predicting ICC was constructed based on specific CEUS features by the least absolute shrinkage and selection operator regularised regression. M-score was used to develop a modified CEUS LI-RADS. The diagnostic performance of the modified CEUS LI-RADS using M-score for diagnosing HCC and ICC was compared with American College of Radiology (ACR) CEUS LI-RADS using LR-M.
RESULTS: The most useful features for ICC were as follows: poorly circumscribed (69.52%), rim enhancement (63.81%), early washout (92.38%), intratumoural vein (56.19%), obscure boundary of intratumoural non-enhanced area (57.14%), and marked washout (59.05%, all p < 0.001). For predicting ICC, the M-score had a higher specificity (88.57% vs. 63.81%) with lower sensitivity (89.52% vs. 95.24%) compared with LR-M. For diagnosing HCC, the sensitivity of modified LI-RADS (80.95%) was much higher than that of ACR LI-RADS (57.14%), but the specificity was lower (90.48% vs. 96.19%). The area under the curve (AUC) of modified LI-RADS (0.857) was much higher than that of ACR LI-RADS (0.767, p = 0.0001). The modified positive predictive value (PPV) of ACR LI-RADS and modified LI-RADS were 99.42% and 98.99%, respectively.
CONCLUSIONS: The modified LI-RADS with M-score had higher sensitivity for diagnosing HCC and higher specificity for diagnosing ICC than ACR LI-RADS. KEY POINTS: • For predicting ICC, the M-score had a higher specificity (88.57% vs. 63.81%) with lower sensitivity (89.52% vs. 95.24%) compared with LR-M. • A CEUS M-score for predicting ICC consisted of more detailed CEUS features (poorly circumscribed, rim enhancement, early washout, intratumoural vein, obscure boundary of intratumoural non-enhanced area, and marked washout) was constructed. • For diagnosing HCC, the sensitivity of modified LI-RADS (80.95%) was much higher than that of ACR LI-RADS (57.14%), but the specificity was lower (90.48% vs. 96.19%). The modified positive predictive value (PPV) of ACR LI-RADS and modified LI-RADS were 99.42% and 98.99%, respectively.

Entities:  

Keywords:  Hepatitis; Hepatocellular carcinoma (HCC); Ultrasonography

Mesh:

Substances:

Year:  2018        PMID: 30569182     DOI: 10.1007/s00330-018-5927-8

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  24 in total

1.  Management of hepatocellular carcinoma.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2005-11       Impact factor: 17.425

2.  Imaging of peripheral cholangiocarcinoma with low-mechanical index contrast-enhanced sonography and SonoVue: initial experience.

Authors:  Hui-Xiong Xu; Ming-De Lu; Guang-Jian Liu; Xiao-Yan Xie; Zuo-Feng Xu; Yan-Ling Zheng; Jin-Yu Liang
Journal:  J Ultrasound Med       Date:  2006-01       Impact factor: 2.153

3.  Contrast-enhanced ultrasound of intrahepatic cholangiocarcinoma: correlation with pathological examination.

Authors:  H-X Xu; L-D Chen; L-N Liu; Y-F Zhang; L-H Guo; C Liu
Journal:  Br J Radiol       Date:  2012-02-28       Impact factor: 3.039

Review 4.  Real-time harmonic contrast material-specific US of focal liver lesions.

Authors:  Orlando Catalano; Antonio Nunziata; Roberto Lobianco; Alfredo Siani
Journal:  Radiographics       Date:  2005 Mar-Apr       Impact factor: 5.333

5.  Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.

Authors:  Masao Omata; Laurentius A Lesmana; Ryosuke Tateishi; Pei-Jer Chen; Shi-Ming Lin; Haruhiko Yoshida; Masatoshi Kudo; Jeong Min Lee; Byung Ihn Choi; Ronnie T P Poon; Shuichiro Shiina; Ann Lii Cheng; Ji-Dong Jia; Shuntaro Obi; Kwang Hyub Han; Wasim Jafri; Pierce Chow; Seng Gee Lim; Yogesh K Chawla; Unggul Budihusodo; Rino A Gani; C Rinaldi Lesmana; Terawan Agus Putranto; Yun Fan Liaw; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2010-03-18       Impact factor: 6.047

6.  Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound.

Authors:  Ramón Vilana; Alejandro Forner; Luis Bianchi; Angeles García-Criado; Jordi Rimola; Carlos Rodríguez de Lope; María Reig; Carmen Ayuso; Concepció Brú; Jordi Bruix
Journal:  Hepatology       Date:  2010-06       Impact factor: 17.425

7.  Intrahepatic cholangiocarcinoma and hepatocellular carcinoma: differential diagnosis with contrast-enhanced ultrasound.

Authors:  Li-Da Chen; Hui-Xiong Xu; Xiao-Yan Xie; Xiao-Hua Xie; Zuo-Feng Xu; Guang-Jian Liu; Zhu Wang; Man-Xia Lin; Ming-De Lu
Journal:  Eur Radiol       Date:  2009-09-04       Impact factor: 5.315

8.  AASLD Practice Guidelines on chronic hepatitis B and HBV infection in Italy.

Authors:  Tommaso Stroffolini; Giovanni Battista Gaeta; Alfonso Mele
Journal:  Hepatology       Date:  2007-08       Impact factor: 17.425

9.  Contrast-enhanced ultrasound (CEUS) for differentiating between hepatocellular and cholangiocellular carcinoma.

Authors:  W Bohle; P U Clemens; T Heubach; W G Zoller
Journal:  Ultraschall Med       Date:  2011-12-22       Impact factor: 6.548

10.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

View more
  5 in total

1.  Using new criteria to improve the differentiation between HCC and non-HCC malignancies: clinical practice and discussion in CEUS LI-RADS 2017.

Authors:  Dan Zeng; Ming Xu; Jin-Yu Liang; Mei-Qing Cheng; Hui Huang; Jia-Ming Pan; Yang Huang; Wen-Juan Tong; Xiao-Yan Xie; Ming-De Lu; Ming Kuang; Li-Da Chen; Hang-Tong Hu; Wei Wang
Journal:  Radiol Med       Date:  2021-10-19       Impact factor: 3.469

Review 2.  Contrast-enhanced ultrasound for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.

Authors:  Mirella Fraquelli; Tin Nadarevic; Agostino Colli; Cristina Manzotti; Vanja Giljaca; Damir Miletic; Davor Štimac; Giovanni Casazza
Journal:  Cochrane Database Syst Rev       Date:  2022-09-02

3.  Conventional, functional and radiomics assessment for intrahepatic cholangiocarcinoma.

Authors:  Vincenza Granata; Roberta Fusco; Andrea Belli; Valentina Borzillo; Pierpaolo Palumbo; Federico Bruno; Roberta Grassi; Alessandro Ottaiano; Guglielmo Nasti; Vincenzo Pilone; Antonella Petrillo; Francesco Izzo
Journal:  Infect Agent Cancer       Date:  2022-03-28       Impact factor: 2.965

4.  Contrast-enhanced ultrasound Liver Imaging Reporting and Data System: Lights and shadows in hepatocellular carcinoma and cholangiocellular carcinoma diagnosis.

Authors:  Gianpaolo Vidili; Marco Arru; Giuliana Solinas; Diego Francesco Calvisi; Pierluigi Meloni; Assunta Sauchella; Davide Turilli; Claudio Fabio; Antonio Cossu; Giordano Madeddu; Sergio Babudieri; Maria Assunta Zocco; Giovanni Iannetti; Enza Di Lembo; Alessandro Palmerio Delitala; Roberto Manetti
Journal:  World J Gastroenterol       Date:  2022-07-21       Impact factor: 5.374

5.  Contrast-enhanced ultrasound Liver Imaging Reporting and Data System category M: a systematic review and meta-analysis.

Authors:  Jaeseung Shin; Sunyoung Lee; Yeun-Yoon Kim; Yong Eun Chung; Jin-Young Choi; Mi-Suk Park
Journal:  Ultrasonography       Date:  2021-05-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.